Maria Teresa Buco

🔎 In focus at #HIMSS24Europe: EU projects! Making impact to healthcare and enhancing citizens lives. 📍Common challenges seen: how procurers can interact with HTA, how to develop trust on AI (by demonstrating value and applicability of data?), and how to scale up so projects have a life beyond the project time (by securing the environment with regulation and data management?) 🍝for 💭 Petra Wilson Marianna Petrea-Imenokhoeva Petra Hoogendoorn Anne Moen Mario Ravic Lisa Hanselmann Chiara Zocchi

67

With the June 20th EPSCO meeting the curtain fell over the BE Presidency in the employment and social affairs filière. It has been an exciting ride to contribute to this work to better identify and incorporate the economic returns of social investments into overall policy development. The March joint meeting of the Employment and Social Affairs Ministers and the Ministers of Economic and financial Affairs to discuss these issues has been an important milestone. Let me add some quick personal thoughts. Enhancing access to #adminsitrativedata for policy monitoring and impact analysis has appeared to be a key issue. While the main data collections like EU-SILC and LFS are perfect for the general monitoring purposes, monitoring and assessing the returns of social investments require (much) more granular data. While the situation differs quite strongly between Member States, there is a widespread need to make progress on more accessible data (of course respecting privacy rules). The same goes for the #timeliness of the data. Both EPSCO and ECOFIN Council formations have now called for more timely data. While different pathways could be explored, for social indicators making (swift) further progress on #Flashestimates is a key priority. The work of the Informal Working Group on Social Investment on bringing together the work by #MemberStates, the #EuropeanCommission, the #EuropeanInvestmentBank, the #WorldBank and the #OECD provides an excellent basis to built upon. Looking forward to further work on this by the #Europeancommission and in the #SocialProtectionCommittee and #EmploymentCommittee and their Indicator Groups. Many thanks for all the support to the colleagues in the EPSCO Committees, the participants in the Informal Working Group on Social Investment and all who contributed!

25

2 Comments

To say the least, it was quite surprising to read yesterday in POLITICO Europe that #Belgium, home to a significant #pharmaceutical sector, supports the European Commission proposal to decrease the Regulatory Data Protection (#RDP) from 8 years to 6 years 🗓️. It's well-known that companies decide where to carry out R&D considering factors such as where science is the strongest 💪, the stability and predictability of the intellectual property framework, available data and technology, manufacturing capabilities and the ability to get the medicines used by patients. While RDP is the last layer of protection for around one in three medicines, it will be factored into the decision-making process of 100% of medicines. This is why not only the pharma industry, but also Member States, research centers, and ultimately, the patients should be concerned by the proposal of the Commission and the Belgian position: 🏳 MEMBER STATES: Decreasing the RDP baseline to 6 years could significantly impact the European Union's (EU) attractiveness for global investments. Over the past few months, we've heard the Commission repeatedly state that every additional year of RDP would result in €1.2 billion in additional costs to Member States. This estimate, however, is based on the 'List Prices of medicines' - the publicly listed price before discounts, rebates, and clawbacks. A research study by the economic research agency, Dolon, has shown that reducing RDP in Europe would on the contrary cost €2 billion a year in lost R&D investment. #Belgium would be one of the most impacted Member States if the proposal of the Commission is adopted: the industry provides there 45,000 direct jobs and accounts for almost 15% of total Belgian exports. Over the last 5 years, the number of researchers working in the sector has increased by over 25%. In 2023, there were 6,706 researchers working in the sector. 🧪 RESEARCHERS: Fewer R&D initiatives in the EU and in Belgium would mean less clinical trials, which would greatly impact especially the academic hospitals, renowned globally as major centers for clinical trials. We often forget that hospitals are crucial players in the global scientific community, contributing to innovative research that shapes the future of medicines. 👩‍🔬 PATIENTS: Fewer clinical trials in Europe and in Belgium would mean less early access to highly innovative treatments answering unmet medical needs. To conclude: The EU is at a crossroads - will it be an innovation hub or a follower in the future? As a region, the EU has already lagged behind global competitors in terms of R&D and manufacturing, with lower investment, a smaller share of global clinical trials, and longer approval times for new medicines over the past 20 years. Belgium seems to have made its choice, let's hope they will reconsider their position 🙏. https://lnkd.in/dkVDyq8w #WeWontRest #EUPharmaLegislation #innovation #competitiveness

39

The Internal Side of Public Affairs (15) Engaging with Extremes: The dilemma for companies & associations In last month’s European Parliament elections far-right groups gained unprecedented representation. For Businesses and Associations this poses a dilemma: how to engage with these new stakeholders. At a Best in Brussels event in June Mark Dober revealed that around 50% of survey respondents would NOT engage the far right. So, should you engage with them, or avoid them? Perhaps you should look to your Associations to do this? This post shares some thoughts on this situation: Why Engagement is Necessary Influence on Policy-Making: Far-right parties now have a tangible impact on legislative processes. Ignoring these stakeholders could lead to unfavourable policies and means you have no influence. Stakeholder Relationships: Effective stakeholder management requires working with all relevant parties, including those with differing views. You need insights into their priorities and concerns so you can navigate the political landscape and maintain a competitive edge. Champion vs. Support: You can work with stakeholders to gather support and help influence positions without having them as your champion (which may be a step too far). How to Engage: Some Considerations Reputation Management: Engaging with far-right stakeholders carries reputational risks from corporate reputational risk to the local political risk that by associating with the far right you alienate support from other political groups. Clear Ethical Guidelines: Establish clear ethical guidelines for engagement, ensuring that interactions with far-right parties do not compromise any of your positions and values. Focus on Common Interests: Identify areas of common interest, such as economic growth, job creation, and technological innovation. Building dialogue around these topics can lead to constructive engagement without endorsing controversial positions. Public Communication: Maintain transparent communication with other stakeholders (and the public) about the nature and purpose of engagement with far-right stakeholders. This helps in managing public perception and mitigating potential backlash. Engaging with these new stakeholders is out of your comfort zone and fraught with complexities. It is, however, necessary and important. The job of Public Affairs professionals is to find the right ways to engage stakeholders for their organization. In an increasingly polarized environment engaging across the aisle will become more and more of an advantage. Share your thoughts and experiences in the comments below! 👇 #PublicAffairs #StrategicImpact #StakeholderEngagement   Pär Nygårds Per-Erik Wolff Dr. Stephen Massey Dimitris Vartholomaios Anders Kopp Paul Shotton Aaron McLoughlin Andras Baneth Wouter Lox Claudia Breure Pieter Walraven Carmen Muñoz Jodar Michel Ehrlich Mickey Langley Kelly Langley Jorge Espinosa de Los Monteros Romero

14

3 Comments

A new EU College of Commissioners and Mission Letters showing what’s ahead for e-mobility. Read them here: https://lnkd.in/ed-6CNYj We have urgent work ahead with this new Commission to restore Europe’s leading e-mobility position and seize the opportunities on offer for investment and new jobs. Two big priorities will be ensuring EU competitiveness and keeping clarity towards 2035 targets. Six key initiatives to prepare for: 1. 𝐂𝐥𝐞𝐚𝐧 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐚𝐥 𝐃𝐞𝐚𝐥, 𝐭𝐨 𝐛𝐞 𝐥𝐞𝐝 𝐛𝐲 𝐒𝐭𝐞𝐩𝐡𝐚𝐧𝐞 𝐒𝐞𝐣𝐨𝐮𝐫𝐧𝐞, 𝐟𝐨𝐜𝐮𝐬𝐬𝐢𝐧𝐠 𝐨𝐧 𝐝𝐞𝐜𝐚𝐫𝐛𝐨𝐧𝐢𝐬𝐚𝐭𝐢𝐨𝐧, 𝐜𝐥𝐞𝐚𝐧 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬, 𝐚𝐧𝐝 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬 —> Europe’s battery supply chain in particular needs swift EU support to scale-up and compete. We have the projects, now let’s ensure they turn into successful final investments. 2. 𝐍𝐞𝐰 𝐬𝐭𝐚𝐭𝐞 𝐚𝐢𝐝 𝐫𝐮𝐥𝐞𝐬 𝐚𝐧𝐝 𝐚𝐧 𝐄𝐔 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 𝐟𝐮𝐧𝐝, 𝐭𝐨 𝐛𝐞 𝐥𝐞𝐝 𝐛𝐲 𝐒𝐭𝐞𝐩𝐡𝐚𝐧𝐞 𝐒𝐞𝐣𝐨𝐮𝐫𝐧𝐞 𝐚𝐧𝐝 𝐓𝐞𝐫𝐞𝐬𝐚 𝐑𝐢𝐛𝐞𝐫𝐚. —> Manufacturing-focussed EU finance is much needed, but will Member States buy in sufficiently for Europe to really compete against the US and China? 3. 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐚𝐦𝐞𝐧𝐝𝐦𝐞𝐧𝐭 𝐨𝐟 2035 𝐂𝐎2 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬 𝐟𝐨𝐫 𝐜𝐚𝐫𝐬, 𝐭𝐨 𝐛𝐞 𝐥𝐞𝐝 𝐛𝐲 𝐖𝐨𝐩𝐤𝐞 𝐇𝐨𝐞𝐤𝐬𝐭𝐫𝐚, 𝐞𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐚 “𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐧𝐞𝐮𝐭𝐫𝐚𝐥 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐢𝐧 𝐰𝐡𝐢𝐜𝐡 𝐞-𝐟𝐮𝐞𝐥𝐬 𝐡𝐚𝐯𝐞 𝐚 𝐫𝐨𝐥𝐞 𝐭𝐨 𝐩𝐥𝐚𝐲” —> Clarity and predictability for Europe’s 2035 zero emission car sales target need to be the priority, and will stay driven by electrification. “Targeted” must stay the key word! 4. 𝐄𝐔 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐚𝐥 𝐩𝐥𝐚𝐧 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐬𝐞𝐜𝐭𝐨𝐫, 𝐭𝐨 𝐛𝐞 𝐥𝐞𝐝 𝐛𝐲 𝐀𝐩𝐨𝐬𝐭𝐨𝐥𝐨𝐬 𝐓𝐳𝐢𝐭𝐳𝐢𝐤𝐨𝐬𝐭𝐚𝐬, 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐨n 𝐌𝐚𝐫𝐢𝐨 𝐃𝐫𝐚𝐠𝐡𝐢’𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧. —> Let’s work to turn this into an action-focussed plan for the full ecosystem to move forward under, from vehicles to batteries to charging to components - with real impact. 5. 𝐀 𝐜𝐥𝐞𝐚𝐧 𝐜𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐟𝐥𝐞𝐞𝐭 𝐩𝐫𝐨𝐩𝐨𝐬𝐚𝐥 𝐚𝐧𝐝 𝐚𝐜𝐭𝐢𝐨𝐧 𝐭𝐨 𝐬𝐰𝐢𝐟𝐭𝐥𝐲 𝐛𝐮𝐢𝐥𝐝 𝐮𝐩 𝐜𝐡𝐚𝐫𝐠𝐢𝐧𝐠 𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐢𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞, 𝐭𝐨 𝐛𝐞 𝐥𝐞𝐝 𝐛𝐲 𝐀𝐩𝐨𝐬𝐭𝐨𝐥𝐨𝐬 𝐓𝐳𝐢𝐭𝐳𝐢𝐤𝐨𝐬𝐭𝐚𝐬 —> Two crucial measures to help boost EU demand for the purchase and use of electric vehicles. If we help more Europeans buy and lease electric, the rest will fall into place much easier. 6. 𝐀𝐧 𝐄𝐥𝐞𝐜𝐭𝐫𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐀𝐜𝐭𝐢𝐨𝐧 𝐏𝐥𝐚𝐧, 𝐥𝐞𝐝 𝐛𝐲 𝐃𝐚𝐧 𝐉𝐨𝐫𝐠𝐞𝐧𝐬𝐞𝐧, 𝐟𝐨𝐜𝐮𝐬𝐬𝐞𝐝 𝐨𝐧 𝐡𝐨𝐦𝐞𝐠𝐫𝐨𝐰𝐧, 𝐜𝐥𝐞𝐚𝐧 𝐞𝐥𝐞𝐜𝐭𝐫𝐢𝐜𝐢𝐭𝐲 —> A big ask we’ve shared with other sectors, from solar to wind to copper And that’s not to mention Maros Sefcovic’s trade portfolio relevant to electric car, battery, and raw material imports, or Jessika Roswall’s work on a chemicals industry package including much needed clarity on PFAS.

88

2 Comments